Foxp3 Expression in Human Cancer Cells
Author Information
Author(s): Karanikas Vaios, Speletas Matthaios, Zamanakou Maria, Kalala Fani, Loules Gedeon, Kerenidi Theodora, Barda Angeliki K, Gourgoulianis Konstantinos I, Germenis Anastasios E
Primary Institution: University of Thessaly, University Hospital of Larissa
Hypothesis
Can Foxp3 expression occur in various tumor types beyond pancreatic carcinoma?
Conclusion
Foxp3 is expressed in cancer cells of various types, suggesting a potential role in tumor immune escape.
Supporting Evidence
- Foxp3 mRNA and protein were detected in all tumor cell lines studied.
- Expression levels of Foxp3 varied widely among different tumor types.
- Foxp3 expression correlated with levels of IL-10 and TGFb1.
Takeaway
This study found that a protein called Foxp3 is present in many types of cancer cells, which might help them avoid being attacked by the immune system.
Methodology
The study analyzed 25 tumor cell lines using RT-PCR, quantitative real-time PCR, immunocytochemistry, and flow cytometry.
Potential Biases
Potential bias in interpreting Foxp3 expression as a marker of tumor infiltration by regulatory T cells.
Limitations
The study does not establish a direct causal relationship between Foxp3 expression and tumor behavior.
Participant Demographics
Tumor cell lines from various origins including lung, colon, breast, melanoma, and leukemia.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website